CN109777879A - For detecting primer, kit and the detection method of NR1H3 gene 95bp missing alternative splicing body - Google Patents
For detecting primer, kit and the detection method of NR1H3 gene 95bp missing alternative splicing body Download PDFInfo
- Publication number
- CN109777879A CN109777879A CN201910242593.5A CN201910242593A CN109777879A CN 109777879 A CN109777879 A CN 109777879A CN 201910242593 A CN201910242593 A CN 201910242593A CN 109777879 A CN109777879 A CN 109777879A
- Authority
- CN
- China
- Prior art keywords
- primer
- gene
- alternative splicing
- splicing body
- nr1h3
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The present invention is provided to detect primer, kit and the detection method of NR1H3 gene 95bp missing alternative splicing body.The primer sequence for detecting NR1H3 gene 95bp missing alternative splicing body is as shown in SEQ ID NO:1-2.The present invention is separated the 95bp missing alternative splicing body of NR1H3 gene using specific primer from a variety of splicing forms of the gene, quantitative analysis is carried out to the expression of NR1H3 gene 95bp missing alternative splicing body, accurately, quickly, conveniently, there is very strong practicability.
Description
Technical field
The present invention relates to field of biotechnology, specifically, being related to for detecting NR1H3 gene 95bp missing alternative splicing
Primer, kit and the detection method of body.
Background technique
Liver X receptor alpha (LXR α/NR1H3) is the member of LXR core superrecepter family, as transcription regulatory factor, activity by
To the adjusting of cholesterol degradation product cholesterol oxidized forms.The physiological function of NR1H3 mainly maintains cholesterol levels, carbon aquation
Close the stable state of object metabolism, lipoprotein metabolism and Fatty synthesis.LXR has the function of adjusting tissue lipid biosynthesis, LXR α shadow
The fat deposition and adipocyte lipid of sound of movement object are metabolized, and are lipogenetic positive regulating factors in muscle.Pig NR1H3 gene exists
Wide expression in tissue, but its a variety of alternative splicing body identification and separation progress it is relatively slow, this is hindered to a certain extent
The research of NR1H3 gene physiological function.Therefore identify a certain spliceosome tissue expression pattern using molecular biology method, into
And illustrating with impetus to its biological function, it is significant.
Structurally, LXRs includes 5 structural domains, i.e. ligand-independent transcriptional activation domains, the DNA of aminoterminal
The transcriptional activation domain of the ligand-dependent of binding structural domain, hinge area, ligand binding domain and c-terminus.DNA binding structural domain includes
One highly conserved zinc fingers, the structural domain start the transcription of target gene in conjunction with target gene specific DNA, regulate and control target base
Because of expression;Hinge area can keep the stability of receptor protein, make receptor while dimerization in conjunction with DNA, regulate and control target gene
Expression.
Alternative splicing body is the one of the major reasons for influencing protein and functioning.Only find that a kind of NR1H3 is cut in pig
Isomers is connect, and detection is cumbersome, time-consuming, accuracy rate is low, therefore needs to develop new detection technique means, deeply to probe into
The biological function of spliceosome lays the foundation.
Summary of the invention
The object of the present invention is to provide for detect the NR1H3 gene 95bp missing primer of alternative splicing body, kit and
Detection method.
Inventor has found that length is the 9th exon of 95bp during to pig NR1H3 gene cloning and functional study
All missings provide a kind of primer for detecting NR1H3 gene 95bp missing alternative splicing body and the examination comprising the primer accordingly
Agent box and detection method can effectively solve the problems, such as that existing detection method program is cumbersome, time-consuming, accuracy rate is low.
In order to achieve the object of the present invention, in a first aspect, NR1H3 gene 95bp missing is variable to cut the present invention is provided to detect
The primer of junctor, including primer NX3-F and NX3-R, their nucleotide sequence is respectively as shown in SEQ ID NO:1-2.
Second aspect, the present invention provide the kit for containing the primer NX3-F and NX3-R.
Further, the kit further includes the primer 18S-F and 18S-R for expanding 18S reference gene, they
Nucleotide sequence is respectively as shown in SEQ ID NO:3-4.
The third aspect, the present invention provides the primer NX3-F and NX3-R or the kit containing above-mentioned primer is detecting
NR1H3 gene 95bp lacks the application in alternative splicing body.
Fourth aspect, the present invention provide a kind of method of detection NR1H3 gene 95bp missing alternative splicing body, including following
Step:
1) sample to be tested total serum IgE is extracted, reverse transcription is at cDNA;
2) using the cDNA of step 1) as template, 18S reference gene is expanded using primer 18S-F and 18S-R qPCR, simultaneously
Alternative splicing body is lacked using primer NX3-F and NX3-R qPCR amplification NR1H3 gene 95bp;
3) amplification curve and melting curve analysis are carried out to the qPCR real-time monitoring result of step 2), using 2-△△CTRelatively
Quantitative approach calculates expression quantity of the NR1H3 gene 95bp missing alternative splicing body in different tissues, with SPSS version
20.0 carry out significance test of difference and are mapped by GraphPad Prism 5.
The reaction system of qPCR are as follows: 2 × SYBR Premix Ex Taq II, 9~11 μ L removes RNA enzyme water 7~8 μ L, 10 μ
M upstream primer 0.3~1 μ L, 10 μM of 0.3~1 μ L, cDNA template of downstream primer, 0.5~2.0 μ L.
Preferably, reaction system are as follows: 2 × SYBR Premix Ex Taq II, 10 μ L removes 7.4 μ L of RNA enzyme water, on 10 μM
Swim primer 0.3 μ L, 10 μM of 0.3 μ L, cDNA template of downstream primer, 2.0 μ L.
The response procedures of qPCR are as follows: 92~96 DEG C of initial denaturation 30s~6min;92~96 DEG C of denaturation 5~12s, 55~65 DEG C
Anneal 25~35s, 35~45 circulations.
Preferably, response procedures are as follows: 95 DEG C of initial denaturation 30s;95 DEG C of denaturation 5s, 59 DEG C of annealing 30s, 45 recycle.
Wherein, 2 × SYBR Premix Ex Taq II includes Ex Taq HS, dNTPs, chlorine containing archaeal dna polymerase
Change magnesium, SYBR Green I and PCR reaction buffer.
The amplified production size of primer 18S-F and 18S-R are 119bp, the amplified production size of primer NX3-F and NX3-R
For 87bp.
Method above-mentioned uses relative quantitation method in step 3), and using lung tissue as outer ginseng, (the outer ginseng of setting is to disappear
Except different batches test error) to calculate the spliceosome opposite in different tissues NR1H3 gene differential expression in different tissues is compared using one-way analysis of variance, as a result with
Average value ± standard error indicates, carries out Multiple range test using Duncan ' s method, P < 0.05 indicates that significant difference, P < 0.01 indicate poor
Heteropolar significant, all statistical analysis are completed with 20.0 software of SPSS version.
It is for NR1H3 gene for detecting the primer of pig NR1H3 gene 95bp missing alternative splicing body in the present invention
The sequence (5 '-of part the 8th exon and exon10 junction after the whole 9th Exon deletion 95bp of mRNA level in-site
TCTGCAGGACCGACTGATGTTCC-3 ', SEQ ID NO:5), design identifies the specific primer NX3- of the alternative splicing body
R;The upstream primer NX3-F of the alternative splicing body is designed on exon10.Primer pair NX3 in this way can only be augmented with 95bp and lack
The spliceosome of mistake, to avoid the interference of other known or unknown NR1H3 gene alternative splicing bodies.
By above-mentioned technical proposal, the present invention at least have following advantages and the utility model has the advantages that
The 95bp of NR1H3 gene is lacked a variety of montages of the alternative splicing body from the gene using specific primer by the present invention
It is separated in form, the expression progress quantitative analysis to NR1H3 gene 95bp missing alternative splicing body, accurate, quick,
It is convenient, there is very strong practicability.
Detailed description of the invention
Fig. 1 is the techniqueflow schematic diagram of the embodiment of the present invention 1.
Fig. 2 is the amplification curve of NR1H3 gene and 18S reference gene in the embodiment of the present invention 1.
Fig. 3 is the melting curve of NR1H3 gene and 18S reference gene in the embodiment of the present invention 1.
Fig. 4 is that pig NR1H3 gene 95bp missing alternative splicing body is relatively fixed in different tissues in the embodiment of the present invention 1
Measure expression.In histogram, the value of pillar is average ± standard error;There is no significant (the P < of identical lowercase letter indication difference
0.05), indicate that difference is extremely significant (P < 0.01) without identical capitalization.
Specific embodiment
The following examples are used to illustrate the present invention, but are not intended to limit the scope of the present invention..Unless otherwise specified, embodiment
According to conventional laboratory conditions, such as Sambrook molecular cloning experiment handbook (Sambrook J&Russell DW,
Molecular Cloning:a Laboratory Manual, 2001), or according to the condition of manufacturer's specification suggestion.
The method that embodiment 1 detects NR1H3 gene 95bp missing alternative splicing body
The techniqueflow schematic diagram of the present embodiment is as shown in Figure 1, mainly comprise the steps that
1, the acquisition of tissue sample
1 monthly age length pig 3, from Datong City, Shanxi Province kind pig farm.After butchering, respectively acquire biceps muscle of thigh (GJ),
Greater psoas muscle (YJ), longissimus dorsi muscle (BJ), dorsal sc fat (BZ), abdominal subcutaneous fat (PZ), heart (X), liver (G), spleen
Dirty (P), lungs (F), kidney (S), stomach (W), small intestine (XC) etc. are put into liquid nitrogen immediately, and it is standby to be subsequently placed at -80 DEG C of refrigerators preservations
With.
2, tissue RNA is extracted and cDNA is synthesized
The total serum IgE of each tissue is extracted using TaKaRa RNAiso Plus kit, extracting method is referring to kit explanation
Book.The integrality of total serum IgE is detected by agarose gel electrophoresis and is determined;Total rna concentration is micro ultraviolet by NanoDrop1000
Spectrophotometric determination.
Using PrimeScript RT reagent Kit with gDNA Eraser (TaKaRa, Dalian, China)
Kit is by RNA reverse transcription at cDNA.
3, design of primers
Pig NR1H3 gene mRNA forecasting sequence (the GenBank Accession No.XM_ announced according to NCBI
013994345.2) design can identify the primer pair NX3 of NR1H3 gene 95bp missing alternative splicing body;It is announced according to NCBI
18S gene order design primer is to 18S.
Primer pair NX3 is (SEQ ID NO:1-2):
Upstream primer, NX3-F:5 '-GCAGGACCGACTGATGTT-3 ';
Downstream primer, NX3-R:5 '-GCAAACACTTGCTCTGAGTG-3 ';
Primer pair 18S is (SEQ ID NO:3-4):
Upstream primer, 18S-F:5 '-ATGCCAGAGTCTCGTTCGTTAT-3 ';
Downstream primer, 18S-R:5 '-CGGACAGGATTGACAGATTGAT-3 '.
It is complete for NR1H3 gene mRNA levels for detecting the primer of pig NR1H3 gene 95bp missing alternative splicing body
The sequence (5 '-of part the 8th exon and exon10 junction after the 9th Exon deletion 95bp of portion
TCTGCAGGACCGACTGATGTTCC-3 '), design identifies the specific primer NX3-F of the alternative splicing body;It is shown outside the 10th
The downstream primer NX3-R of the alternative splicing body is designed on son.Primer pair NX3 in this way can only be augmented with the spliceosome of 95bp missing,
To avoid the interference of other known or unknown NR1H3 gene alternative splicing bodies.
4, fluorescent quantitative PCR
Quantitative fluorescent PCR reaction system is using mixing sample-adding method, the i.e. various components according to needed for each reaction system
Quantity and 1 secondary response needed for PCR react number, calculate the total amount of various reactive components, be added to 1 and go RNA enzyme
In 1.5mL centrifuge tube, rear brief centrifugation is mixed well, then is dispensed into dedicated 8 union of quantitative fluorescent PCR, is then added respectively
Enter template cDNA, then carry out fluorescent quantitative PCR after brief centrifugation, whole operation process is protected from light as far as possible;Quantitative fluorescent PCR is anti-
System is answered to be shown in Table 1.Response procedures are as follows: 95 DEG C of initial denaturation 30s;95 DEG C of denaturation 5s, 59 DEG C of annealing 30s, 45 recycle.
1 quantitative fluorescent PCR reaction system of table
5, quantitative fluorescent PCR data are analyzed
The amplification for carrying out NR1H3 gene 95bp missing alternative splicing body and reference gene 18S to fluorescent quantitative PCR result is bent
Line (Fig. 2) and melting curve (Fig. 3) analysis.Each gene magnification curve is in serpentine and reaches plateau in Fig. 2, is illustrated to have
Effect amplification;Each gene melting curve peak value is single in Fig. 3, illustrates amplified production special, primer free dimer and other are non-specific
Property amplification, the analysis of subsequent result can be carried out.The CT value respectively organized according to pig, using lung tissue as outer ginseng (the outer ginseng of setting
It is to eliminate different batches test error), it is calculated using relative quantitation method
6, distribution expression pattern charts
According to the calculated result of relative quantification, significance test of difference is carried out using 20.0 software of SPSS version, and
The tissue expression map of the spliceosome is made by GraphPad Prism 5, as a result as shown in Figure 4.Individual repeat number is in figure
3, qPCR loading techniques repeat to be 3.
The 95bp of NR1H3 gene can be lacked alternative splicing body from the gene using specific primer provided by the invention
It is separated in a variety of splicing forms, quantitative analysis is carried out to the expression of NR1H3 gene 95bp missing alternative splicing body, it is quasi-
Really, quickly, conveniently, there is very strong practicability.
Although above the present invention is described in detail with a general description of the specific embodiments,
On the basis of the present invention, it can be modified or is improved, this will be apparent to those skilled in the art.Cause
This, these modifications or improvements, fall within the scope of the claimed invention without departing from theon the basis of the spirit of the present invention.
Sequence table
<110>Agricultural University Of Shanxi
<120>for detecting primer, kit and the detection method of 95 bp of NR1H3 gene missing alternative splicing body
<130> KHP191111130.8
<160> 5
<170> SIPOSequenceListing 1.0
<210> 1
<211> 18
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 1
gcaggaccga ctgatgtt 18
<210> 2
<211> 20
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 2
gcaaacactt gctctgagtg 20
<210> 3
<211> 22
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 3
atgccagagt ctcgttcgtt at 22
<210> 4
<211> 22
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 4
cggacaggat tgacagattg at 22
<210> 5
<211> 23
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 5
tctgcaggac cgactgatgt tcc 23
Claims (8)
1. the primer for detecting NR1H3 gene 95bp missing alternative splicing body, which is characterized in that including primer NX3-F and
NX3-R, their nucleotide sequence is respectively as shown in SEQ ID NO:1-2.
2. the kit containing primer described in claim 1.
3. kit according to claim 2, which is characterized in that the kit further includes for expanding 18S internal reference base
The primer 18S-F and 18S-R of cause, their nucleotide sequence is respectively as shown in SEQ ID NO:3-4.
4. kit described in primer or Claims 2 or 3 described in claim 1 can be changed in detection NR1H3 gene 95bp missing and cut
Application in junctor.
5. a kind of method of detection NR1H3 gene 95bp missing alternative splicing body, which comprises the following steps:
1) sample to be tested total serum IgE is extracted, reverse transcription is at cDNA;
2) using the cDNA of step 1) as template, 18S reference gene is expanded using primer 18S-F and 18S-R qPCR, is utilized simultaneously
Primer NX3-F and NX3-R qPCR expand NR1H3 gene 95bp and lack alternative splicing body;
3) amplification curve and melting curve analysis are carried out to the qPCR real-time monitoring result of step 2), using 2-△△CTRelative quantification
Method calculates expression quantity of the NR1H3 gene 95bp missing alternative splicing body in different tissues, with SPSS version 20.0 into
Row significance test of difference is simultaneously mapped by GraphPad Prism 5.
6. according to the method described in claim 5, it is characterized in that, in step 2) qPCR reaction system are as follows: 2 × SYBR
9~11 μ L of Premix Ex Taq II goes 7~8 μ L of RNA enzyme water, 10 μM of 0.3~1 μ L of upstream primer, 10 μM of downstream primers 0.3
0.5~2.0 μ L of~1 μ L, cDNA template;
Preferably, reaction system are as follows: 2 × SYBR Premix Ex Taq II, 10 μ L removes 7.4 μ L of RNA enzyme water, and 10 μM of upstreams are drawn
Object 0.3 μ L, 10 μM of 0.3 μ L, cDNA template of downstream primer, 2.0 μ L.
7. according to the method described in claim 5, it is characterized in that, in step 2) qPCR response procedures are as follows: 92~96 DEG C are pre-
It is denaturalized 30s~6min;92~96 DEG C of 5~12s of denaturation, 55~65 DEG C of 25~35s of annealing, 35~45 recycle;
Preferably, response procedures are as follows: 95 DEG C of initial denaturation 30s;95 DEG C of denaturation 5s, 59 DEG C of annealing 30s, 45 recycle.
8. according to the method described in claim 6, it is characterized in that, the Ex Taq of 2 × SYBR Premix described in step 2) II
Including Ex Taq HS, dNTPs, magnesium chloride, SYBR Green I and PCR reaction buffer containing archaeal dna polymerase.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910242593.5A CN109777879A (en) | 2019-03-28 | 2019-03-28 | For detecting primer, kit and the detection method of NR1H3 gene 95bp missing alternative splicing body |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910242593.5A CN109777879A (en) | 2019-03-28 | 2019-03-28 | For detecting primer, kit and the detection method of NR1H3 gene 95bp missing alternative splicing body |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109777879A true CN109777879A (en) | 2019-05-21 |
Family
ID=66490768
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910242593.5A Pending CN109777879A (en) | 2019-03-28 | 2019-03-28 | For detecting primer, kit and the detection method of NR1H3 gene 95bp missing alternative splicing body |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109777879A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110218724A (en) * | 2019-06-13 | 2019-09-10 | 山西农业大学 | The detection of the construction method and its expression of pig NR1H3 gene overexpression vector plasmid |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102421915A (en) * | 2009-02-25 | 2012-04-18 | 蒂雅卡特有限责任公司 | Free circulating dna bio-markers and their applications |
CN104673912A (en) * | 2015-02-13 | 2015-06-03 | 河南农业大学 | Primer, kit and detection method for detecting 245bp deletion alternative spliceosome of LEPR gene |
-
2019
- 2019-03-28 CN CN201910242593.5A patent/CN109777879A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102421915A (en) * | 2009-02-25 | 2012-04-18 | 蒂雅卡特有限责任公司 | Free circulating dna bio-markers and their applications |
CN104673912A (en) * | 2015-02-13 | 2015-06-03 | 河南农业大学 | Primer, kit and detection method for detecting 245bp deletion alternative spliceosome of LEPR gene |
Non-Patent Citations (4)
Title |
---|
GAVINI CK等: "Mus musculus nuclear receptor subfamily 1, group H, member 3 (Nr1h3), transcript variant 3, mRNA,NCBI Reference Sequence: NM_001355279.1,1734bp mRNA linear", 《NCBI GENBANK》 * |
NCBI GENBANK: "PREDICTED: Bubalus bubalis nuclear receptor subfamily 1 group H member 3 (NR1H3), transcript variant X3, mRNA,NCBI Reference Sequence: XM_025266090.1,1632bp mRNA linear", 《NCBI GENBANK》 * |
NCBI GENBANK: "PREDICTED: Ovis aries nuclear receptor subfamily 1 group H member 3 (NR1H3), transcript,variant X6, mRNA,NCBI Reference Sequence: XM_012096370.3,1581bp mRNA linear", 《NCBI GENBANK》 * |
王敏玉等: "微RNA-198在结直肠癌中调控Elf3的表达并抑制细胞增殖", 《肿瘤》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110218724A (en) * | 2019-06-13 | 2019-09-10 | 山西农业大学 | The detection of the construction method and its expression of pig NR1H3 gene overexpression vector plasmid |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108949990A (en) | A kind of kit and method detecting EGFR genetic mutation | |
CN108676872B (en) | One kind biomarker relevant to asthma and its application | |
CN106591477A (en) | Method of using multiple reference gene combinations to study yak embryo gene | |
CN110373474A (en) | The relevant genetic marker of Gansu Province east Cashmere Goat diameter and its application | |
CN107312852A (en) | Myocardial infarction diagnosis mark compositions | |
CN107254543B (en) | PCR primer combination, kit and real-time fluorescent quantitative detection method for detecting RhD mRNA spliceosome | |
CN109777879A (en) | For detecting primer, kit and the detection method of NR1H3 gene 95bp missing alternative splicing body | |
CN103374575A (en) | CYP4V2 gene mutant and application thereof | |
CN109825560A (en) | For detecting primer, kit and the detection method of C1QTNF3 gene 219bp missing alternative splicing body | |
CN112126691B (en) | Method, primer, kit and application for auxiliary detection of pig backfat thickness character by using pig chromosome 2 gene polymorphism site | |
Nakanishi et al. | A comparison of splicing assays to detect an intronic variant of the OCRL gene in Lowe syndrome | |
CN110029156A (en) | A kind of method and its application of detection tea card sheep KAT6A gene C NV label | |
CN105441565A (en) | miRNA regarding as osteosarcoma treatment target | |
CN107312851A (en) | Myocardial infarction biomarker miR 1283 | |
CN110157818A (en) | One kind molecular labeling relevant to pig eye muscle high-yield character and its application | |
Erdmann et al. | Screening the human bradykinin B2 receptor gene in patients with cardiovascular diseases: identification of a functional mutation in the promoter and a new coding variant (T21M) | |
CN105734155B (en) | Chondroblastic osteosarcoma Disease-causing gene and its application | |
CN110885889A (en) | Method for identifying pig backfat thickness based on rs81469622 locus genotype and application | |
CN104673912B (en) | A kind of primer for detecting LEPR gene 245bp deletion alternative splicing bodies, kit and detection method | |
CN105838804A (en) | MiR-17-5p hematological malignancy auxiliary diagnosis reagent and application | |
CN111394451A (en) | Insulin resistance gene polymorphism detection primer, application and kit thereof | |
CN109652529A (en) | Osteoporosis specificity miRNA, composition and its diagnostic use | |
CN115851907B (en) | Annular non-coding RNA-circZBTB46 and application thereof | |
CN110093425A (en) | A kind of method and its application of detection Small-fat-tail sheep ORMDL1 gene C NV label | |
CN113943791B (en) | Application of UC002yug.2-rs2246640 as female obesity biomarker |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20190521 |